Skip to main content

Advertisement

Log in

Multifocality and Total Tumor Diameter Predict Central Neck Lymph Node Metastases in Papillary Thyroid Microcarcinoma

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

To identify the subgroup of high-risk papillary thyroid microcarcinoma (PTMC) inclined to lymph node metastasis (LNM).

Methods

Patients who underwent total thyroidectomy with central neck dissection and had a pathologic diagnosis of PTMC between 2003 and 2010 at Wuhan Union Hospital were identified. The frequency of LNM was retrospectively analyzed according to the clinicopathological features. For multifocal lesions, total tumor diameter (TTD) was calculated as the sum of the maximal diameter of each lesion. Last, a meta-analysis was performed with respect to multifocality and LNM in the PTMCs.

Results

The proportion of LNM was similar between multifocal PTMCs with TTD ≤ 1 cm and unifocal tumors with diameter ≤ 1 cm (37.5 vs. 30 %, P = 0.463). LNM frequency was also similar between multifocal PTMCs with 1 < TTD ≤ 2 cm (TTD greater than 1 cm but less than or equal to 2 cm) and unifocal tumors with 1 < diameter ≤ 2 cm (56.8 vs. 64.9 %, P = 0.330). However, LNM frequency was significantly higher in multifocal PTMCs with TTD > 1 cm than unifocal tumors with diameter ≤ 1 cm (60.4 vs. 30 %, P < 0.001). A meta-analysis of nine publications plus our own data with a total 1,586 PTMCs demonstrated that multifocality was significantly associated with LNM risk (odds ratio 1.9, 95 % confidence interval 1.5–2.4).

Conclusions

Multifocal PTMC with TTD > 1 cm has a similar risk of LNM as a clinical papillary cancer. Routine central neck dissection is recommended in this subgroup of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Sobin L. Histological typing of thyroid tumours. Histopathology. 1990;16:513.

    Article  PubMed  CAS  Google Scholar 

  2. Lin JD. Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer. Med Oncol. 2010;27:510–8.

    Article  PubMed  Google Scholar 

  3. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer. 2009;115:3801–7.

    Article  PubMed  Google Scholar 

  4. Giordano D, Gradoni P, Oretti G, et al. Treatment and prognostic factors of papillary thyroid microcarcinoma. Clin Otolaryngol. 2010;35:118–24.

    Article  PubMed  CAS  Google Scholar 

  5. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–7.

    Article  PubMed  CAS  Google Scholar 

  6. Kutler DI, Crummey AD, Kuhel WI. Routine central compartment lymph node dissection for patients with papillary thyroid carcinoma. Head Neck. 2012;34:260–3.

    Article  PubMed  Google Scholar 

  7. Garrel R, Tripodi C, Cartier C, et al. Cervical lymphadenopathies signaling thyroid microcarcinoma. Case study and review of the literature. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:115–9.

    Google Scholar 

  8. Xiang J, Wu Y, Li DS, et al. New clinical features of thyroid cancer in eastern China. J Visc Surg. 2010;147:e53–6.

    Article  PubMed  CAS  Google Scholar 

  9. Moreno MA, Agarwal G, de Luna R, et al. Preoperative lateral neck ultrasonography as a long-term outcome predictor in papillary thyroid cancer. Arch Otolaryngol Head Neck Surg. 2011;137:157–62.

    Article  PubMed  Google Scholar 

  10. Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008;144:980–7.

    Article  PubMed  Google Scholar 

  11. Pisanu A, Reccia I, Nardello O, et al. Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J Surg. 2009;33:460–8.

    Article  PubMed  Google Scholar 

  12. Vaisman F, Shaha A, Fish S, Tuttle R. Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer. Clin Endocrinol (Oxf) (in press).

  13. Lundgren CI, Hall P, Dickman PW, et al. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case–control study. Cancer. 2006;106:524–31.

    Article  PubMed  Google Scholar 

  14. Solorzano CC, Carneiro DM, Ramirez M, et al. Surgeon-performed ultrasound in the management of thyroid malignancy. Am Surg. 2004;70:576–80.

    PubMed  Google Scholar 

  15. Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab. 2007;92:3590–4.

    Article  PubMed  CAS  Google Scholar 

  16. Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope. 2011;121:487–91.

    Article  PubMed  Google Scholar 

  17. Ito Y, Tomoda C, Uruno T, et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg. 2006;30:91–9.

    Article  PubMed  Google Scholar 

  18. DeLellis RA. Pathology and genetics of tumours of endocrine organs. Lyon: World Health Organization, 2004.

    Google Scholar 

  19. Chun L, Ping, Li Z, Huang T. Operational mode for differentiated thyroid cancer and correlated complications. Acta Metal. Sin. 2007;27:1–856.

    Google Scholar 

  20. Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 1 Sep 2012.

  21. Shao Y, Cai XJ, Gao L, et al. Clinical factors related to central compartment lymph node metastasis in papillary thyroid microcarcinoma: clinical analysis of 117 cases. Zhonghua Yi Xue Za Zhi. 2009;89:403–5.

    PubMed  Google Scholar 

  22. Xu Y, Wang J. Analysis of lymph node metastasis factors in papillary thyroid microcarcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2007;21:679–82.

    PubMed  Google Scholar 

  23. Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237:399–407.

    PubMed  Google Scholar 

  24. Lim YC, Choi EC, Yoon YH, et al. Central lymph node metastases in unilateral papillary thyroid microcarcinoma. Br J Surg. 2009;96:253–7.

    Article  PubMed  CAS  Google Scholar 

  25. Wang Y, Ji QH, Huang CP, et al. Predictive factors for level VI lymph node metastasis in papillary thyroid microcarcinoma. Zhonghua Wai Ke Za Zhi. 2008;46:1899–901.

    PubMed  Google Scholar 

  26. Ito Y, Miyauchi A. Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma. World J Surg. 2008;32:729–39.

    Article  PubMed  Google Scholar 

  27. So YK, Son YI, Hong SD, et al. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections. Surgery. 2010;148:526–31.

    Article  PubMed  Google Scholar 

  28. Lee SH, Lee SS, Jin SM, et al. Predictive factors for central compartment lymph node metastasis in thyroid papillary microcarcinoma. Laryngoscope. 2008;118:659–62.

    Article  PubMed  Google Scholar 

  29. Barbaro D, Simi U, Meucci G, et al. Thyroid papillary cancers: microcarcinoma and carcinoma, incidental cancers and non-incidental cancers—are they different diseases? Clin Endocrinol (Oxf). 2005;63:577–81.

    Article  CAS  Google Scholar 

  30. Ogilvie JB, Patel KN, Heller KS. Impact of the 2009 American Thyroid Association guidelines on the choice of operation for well-differentiated thyroid microcarcinomas. Surgery. 2010;148:1222–6.

    Article  PubMed  Google Scholar 

  31. Mercante G, Frasoldati A, Pedroni C, et al. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid. 2009;19:707–16.

    Article  PubMed  CAS  Google Scholar 

  32. Connor MP, Wells D, Schmalbach CE. Variables predictive of bilateral occult papillary microcarcinoma following total thyroidectomy. Otolaryngol Head Neck Surg. 2011;144:210–5.

    Article  PubMed  Google Scholar 

  33. Dunki-Jacobs E, Grannan K, McDonough S, et al. Clinically unsuspected papillary microcarcinomas of the thyroid: a common finding with favorable biology? Am J Surg. 2012;203:140–4.

    Article  PubMed  Google Scholar 

  34. Siassakos D, Gourgiotis S, Moustafellos P, et al. Thyroid microcarcinoma during thyroidectomy. Singapore Med J. 2008;49:23–5.

    PubMed  CAS  Google Scholar 

  35. Ciuffreda L, De Martino D, Bonfitto N, et al. Our experience on surgical treatment of papillary thyroid microcarcinoma. G Chir. 2011;32:41–4.

    PubMed  CAS  Google Scholar 

  36. Lombardi CP, Bellantone R, De Crea C, et al. Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area. World J Surg. 2010;34:1214–21.

    Article  PubMed  Google Scholar 

  37. Gulben K, Berberoglu U, Celen O, et al. Incidental papillary microcarcinoma of the thyroid—factors affecting lymph node metastasis. Langenbecks Arch Surg. 2008;393:25–9.

    Article  PubMed  Google Scholar 

  38. Chow SM, Law SC, Chan JK, et al. Papillary microcarcinoma of the thyroid—prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98:31–40.

    Article  PubMed  Google Scholar 

  39. Yang GC, LiVolsi VA, Baloch ZW. Thyroid microcarcinoma: fine-needle aspiration diagnosis and histologic follow-up. Int J Surg Pathol. 2002;10:133–9.

    Article  PubMed  Google Scholar 

  40. Neuhold N, Schultheis A, Hermann M, et al. Incidental papillary microcarcinoma of the thyroid—further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up. Ann Surg Oncol. 2011;18:3430–6.

    Article  PubMed  Google Scholar 

  41. Jacquot-Laperriere S, Timoshenko AP, Dumollard JM, et al. Papillary thyroid microcarcinoma: incidence and prognostic factors. Eur Arch Otorhinolaryngol. 2007;264:935–9.

    Article  PubMed  Google Scholar 

  42. Besic N, Pilko G, Petric R, et al. Papillary thyroid microcarcinoma: prognostic factors and treatment. J Surg Oncol. 2008;97:221–5.

    Article  PubMed  Google Scholar 

  43. Lin JD, Chao TC, Hsueh C, et al. High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol. 2009;16:2609–16.

    Article  PubMed  Google Scholar 

  44. Page C, Biet A, Boute P, et al. “Aggressive papillary” thyroid microcarcinoma. Eur Arch Otorhinolaryngol. 2009;266:1959–63.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tao Huang MD, PhD.

Additional information

Qunzi Zhao and Jie Ming contributed equally to this article.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, Q., Ming, J., Liu, C. et al. Multifocality and Total Tumor Diameter Predict Central Neck Lymph Node Metastases in Papillary Thyroid Microcarcinoma. Ann Surg Oncol 20, 746–752 (2013). https://doi.org/10.1245/s10434-012-2654-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-012-2654-2

Keywords

Navigation